After losing his father to cancer at age 13, Robert Figlin, MD, deputy director of Integrated Oncology at Cedars-Sinai, turned his childhood tragedy into a career of breakthroughs — bringing the newest precision treatments to patients, faster. Learn about breakthroughs Read On
Keith L. Black, MD, chair of Neurosurgery, discusses a cutting-edge technology that maps the brain’s pathways during surgery. Read more about Dr. Black and the BrightMatter Guide in Seeing Through the Machine’s Eye from the Spring 2017 issue of Discoveries Read On
Can a series of blows to the head lead to amyotrophic lateral sclerosis (ALS)? Two studies at Cedars-Sinai have provided some early answers and guidance for future research.
Research at Cedars-Sinai shows cutting off specific nerves to the kidney actually could improve insulin’s effectiveness in the liver and have a positive outcome for diabetic patients.
Cedars-Sinai is dedicated to caring for the most vulnerable patients: Among them are infants born prematurely, newborns who require help breathing, and babies born with life-threatening conditions.
Dr. Jon Sin exemplifies the role postdoctoral scientists play in Cedars-Sinai’s research efforts. Photo: Al Cuizon Cedars-Sinai is considered a leader in biomedical science for at least 144 reasons — which is the exact number of postdoctoral scientists who work Read On
The Schimmelbusch mask, invented in 1890 and named for its German creator, introduced a portable, hygienic way to put someone under for surgery.
After years of failure, immunotherapy finally is working wonders for some cancers, transforming death sentences into long-term remission. The problem? It doesn’t work in most cancers — at least, not yet.